Justin Hirsch

Octagon Capital Advisors Lp

Assets Managed

$903.606M

Holdings

Last Quarter

2026 - Q1

Filed Date

18d ago

Growth Rate

9.71%(2Q avg: 17.28%)

Sustained Growth

3 quarters

Portfolio positions

This chart displays the top 10 holdings in Octagon Capital Advisors Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 29 positions.

Assets under management

The assets under management (AUM) of Octagon Capital Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 903.606M in assets, with a quarterly growth rate of 9.71% and a 2-quarter average growth rate of 17.28%. The portfolio is managed by Justin Hirsch, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
DNTH Dianthus Therapeutics Inc Recent Activity Decreased -19.44%	18.08%	$163.364M 1.947M shares@ $83.93 avg price	Decreased -19.44%
COGT Cogent Biosciences Inc Recent Activity	10.02%	$90.451M 2.35M shares@ $38.49 avg price
ABVX Abivax Sa-adr Recent Activity Decreased -10.44%	8.35%	$75.384M 677,000 shares@ $111.35 avg price	Decreased -10.44%
ALMS Alumis Inc Recent Activity Increased 11.86%	6.91%	$62.36M 2.831M shares@ $22.03 avg price	Increased 11.86%
DFTX Definium Therapeutics Inc Recent Activity New Position	5.11%	$46.116M 2.44M shares@ $18.9 avg price	New Position
AVBP Arrivent Biopharma Inc Recent Activity	5.04%	$45.472M 1.971M shares@ $23.08 avg price
TSHA Taysha Gene Therapies Inc Recent Activity	4.39%	$39.604M 8.86M shares@ $4.47 avg price
KYMR Kymera Therapeutics Inc Recent Activity Decreased -20.56%	3.92%	$35.398M 425,000 shares@ $83.29 avg price	Decreased -20.56%
MIRM Mirum Pharmaceuticals Inc Recent Activity New Position	3.47%	$31.308M 338,900 shares@ $92.38 avg price	New Position
BIOA Bioage Labs Inc Recent Activity Increased 9.39%	3.39%	$30.573M 1.748M shares@ $17.49 avg price	Increased 9.39%

1-10 of 29